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The human immunodeficiency virus (HIV-1) causes various hematopoietic abnormalities, with thrombocytopenia (TP)
occurring in 30% of infected individuals. In the present study, we aimed to determine whether HIV-1 in the bone marrow of
TP patients can infect primary megakaryocytes in vitro, which may contribute to the development of thrombocytopenia. We
amplified the V3 loop of HIV-1 envelope from the bone marrow of TP and non-TP patients and constructed recombinant
viruses. We demonstrate that the bone marrow of TP and non-TP patients contained R5 strains, whereas X4 strains were
present only in the bone marrow of TP patients. Furthermore, HIV-1 from the bone marrow of TP and non-TP patients infected
megakaryocytes to similar levels, suggesting that the V3 loop of HIV-1 may not contain the viral determinants of HIV-
associated TP. Chemokine receptor analysis determined that CD341-cell-derived megakaryocytes express CD4, CXCR4, and
CCR5 and are productively infected by both X4 and R5 HIV-1 isolates. Finally, we showed that CD341-cell-derived
megakaryocytes express the chemokine receptor CCR3. © 2000 Academic PressINTRODUCTION
Human immunodeficiency virus (HIV-1) infection sup-
presses bone marrow hematopoiesis and causes vari-
ous peripheral blood cytopenias (Harbol et al., 1994;
Fauci, 1996; Jenkins et al., 1998; Koka et al., 1998; Moses
t al., 1998). Thrombocytopenia (TP) is the most common
orm of cytopenia in HIV-1-infected patients and occurs
n ;30% of cases (Ratner, 1989; Harbol et al., 1994).
IV-associated TP (platelet count , 100,000 mm3 in the
absence of opportunistic infections, neoplasms, and an-
tiretroviral drug therapy) is a multifactorial disorder in-
volving immune destruction of platelets in the periphery
and reduced thrombocytopoiesis in the bone marrow
(Walsh et al., 1984; Ratner, 1989; Ballem et al., 1992; Zauli
et al., 1996). HIV-1 has been implicated in the reduction
of bone marrow thrombocytopoiesis by several studies.
HIV-1 transcripts have been detected in megakaryocytes
of TP patients (Zucker-Franklin and Cao, 1989; Louache
et al., 1991) and ineffective thrombocytopoiesis has been
reported in these patients (Zauli et al., 1991; Ballem et al.,
1992; Cole et al., 1998). In addition, megakaryocyte mor-
phology has been reported to be abnormal in TP patients
(Zucker-Franklin et al., 1989) and zidovudine treatment
has been shown to improve platelet counts in these
patients (Oksenhendler et al., 1989; Boyar and Beall,
1991). Most importantly, it has been suggested that HIV-1
infection of bone marrow megakaryocytes may contrib-
ute to the development of thrombocytopenia (Louache et
al., 1991; Monte et al., 1992; Chelucci et al., 1998). How-
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78ever, conflicting results have been reported on the ability
of HIV-1 to infect primary megakaryocytes and their pre-
cursors (Louache et al., 1992; Zauli et al., 1992a; De Luca
et al., 1993; Zauli and Davis, 1993), questioning the hy-
pothesis that HIV-1 infection of bone marrow megakaryo-
cytes may be one of the contributing factors in the de-
velopment of thrombocytopenia.
In this study we aimed to determine whether HIV-1
from the bone marrow of TP and non-TP patients could
infect primary megakaryocytes in vitro. We analyzed
HIV-1 from the bone marrow because it has been shown
that the HIV-1 quasispecies varies in different cellular
compartments (Donaldson et al., 1994; Delwart et al.,
1998; Poss et al., 1995; van’t Wout et al., 1998; Voulgaro-
poulou et al., 1999). Recombinant HIV-1 strains were
constructed using the hypervariable loop 3 (V3) of HIV-1
envelope from the bone marrow of TP and non-TP pa-
tients (Voulgaropoulou et al., 1999). We showed that
HIV-1 strains from the bone marrow of TP patients were
more pathogenic in vitro than HIV-1 strains from the bone
marrow of non-TP controls (Voulgaropoulou et al., 1999).
Specifically, four of six HIV-1 strains from the bone mar-
row of TP patients replicated in T-cell lines or primary
macrophages, whereas HIV-1 strains from the bone mar-
row of non-TP patients did not replicate in T-cell lines
and only one of five strains replicated in primary macro-
phages (Table 1) (Voulgaropoulou et al., 1999). In this
report we identified the chemokine receptor molecules
utilized by bone marrow HIV-1 for entry into susceptible
cells and the chemokine receptor molecules expressed
on CD341-cell-derived megakaryocytes. Finally, we
showed that both X4 and R5 HIV-1 strains productively
infected primary megakaryocytes in vitro.
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79PRODUCTIVE INFECTION OF MEGAKARYOCYTESRESULTS
oreceptor utilization of bone marrow HIV-1
olecular clones
This study includes 6 HIV-1-infected patients. Patients
, B, and C were diagnosed with HIV-associated TP,
atient D was diagnosed with nocardia infection in the
one marrow, and Patients J and K were diagnosed with
odgkin’s disease (Voulgaropoulou et al., 1999). Bone
arrow aspirates and blood were obtained after in-
ormed consent, and DNA sequences encoding the V3
oop of HIV-1 envelope were amplified by nested poly-
erase chain reaction (Voulgaropoulou et al., 1999).
leven HIV-1 recombinant clones were constructed from
he bone marrow of three TP (A, B, and C) and three
on-TP patients (D, J, and K), and two recombinant
lones were constructed from the blood of two patients (J
nd K) (Table 1) (Voulgaropoulou et al., 1999). To identify
he chemokine receptors utilized by the recombinant
IV-1 clones for entry into susceptible cells, GHOST
ells expressing CXCR4, CCR5, and CCR3 chemokine
eceptors were infected with the molecular clones listed
TABLE 1
Co-receptor Utilization of HIV-1 Molecular Clones
Molecular
clonea Tropismb CXCR4
GHOSTc
CCR5 CCR3
A/BM9 T 1 1 1
B/BM1 PBMC 2 1 2
B/BM4 PBMC 2 1 2
B/BM8 T 1 1 2
C/BM6 M 2 1 2
C/BM11 M 2 1 2
D/BM12 PBMC 2 1 2
D/BM13 PBMC 2 1 2
J/BM2 2 2 1 2
J/BM11 PBMC 2 1 2
K/BM15 M 2 1 1
J/Bld47 T 2 1 2
K/Bld1 M 2 1 2
p120 T 1 1 1
p125 M 1 1 2
a HIV-1 molecular clones from TP patients include A/BM9, B/BM1,
/BM4, B/BM8, C/BM6, and C/BM11. BM designates bone marrow
IV-1 strains and Bld designates blood HIV-1 strains. p120 and p125
re T-cell and macrophage tropic laboratory adapted HIV-1 molecular
lones (Voulgaropoulou et al., 1999).
b HIV-1 molecular clones capable of replication in primary macro-
phages or T-cell lines are designated as M or T, respectively. HIV-1
molecular clones capable of replication in peripheral blood mononu-
clear cells only are designated as PBMC. Replication competent mo-
lecular clones incapable of replication in PBMC, macrophages, or
T-cell lines are designated by dashes (Voulgaropoulou et al., 1999).
c Dashes represent background levels of RT activity (3 3 103 to 5 3
03 cpm/ml) and 1 represents levels of RT activity above background.n Table 1. None of the molecular clones was able to
eplicate in GHOST parental cells, except p120, whicheplicated to low levels due to the presence of endoge-
ous CXCR4 on the surface of these cells (data not
hown). All bone marrow and blood isolates were able to
eplicate in GHOST–CCR5 cells (R5) regardless of their
bility to replicate in primary macrophages (Table 1). The
-cell tropic isolates A/BM9 and B/BM8 were able to
eplicate in GHOST–CXCR4 cells (X4), whereas the T-cell
ropic isolate J/Bld47 did not replicate in these cells,
uggesting that J/Bld47 was unable to utilize CXCR4 for
ntry into GHOST cells (Table 1). Finally, one TP (A/BM9)
nd one non-TP (K/BM15) isolate replicated in GHOST–
CR3 cells (Table 1). The reference T-cell tropic molec-
lar clone p120 (Voulgaropoulou et al., 1999) was able to
eplicate in GHOST–CXCR4 cells very efficiently but less
fficiently in GHOST–CCR5 and -CCR3 cells, suggesting
hat p120 can utilize mainly CXCR4 but also CCR5 and
CR3 to enter susceptible cells (Table 1). The reference
acrophage tropic molecular clone p125 (Voulgaropou-
ou et al., 1999) was able to replicate in GHOST–CCR5
ells very efficiently but less efficiently in GHOST–CXCR4
ells, suggesting that p125 can utilize mainly CCR5 but
lso CXCR4 for entry into susceptible cells (Table 1).
one of the molecular clones was able to replicate in
HOST cells expressing CCR1, CCR2b, CCR8, BOB,
ONZO, and V28 chemokine receptors except p120,
hich was able to replicate in GHOST–CCR1 and
CCR2b cells (data not shown). Therefore the bone mar-
ow of TP patients is characterized by the presence of
oth X4 and R5 HIV-1 strains whereas, only R5 HIV-1
trains were present in the bone marrow of non-TP
atients.
hemokine receptor profile of CD341-cell-derived
egakaryocytes
CD341 hematopoietic progenitor cells were grown
n serum-free media supplemented with 50 mg/ml
hrombopoietin (Tpo) for 7 days. Under these condi-
ions, CD341 hematopoietic progenitor cells have
een shown to differentiate into CD411 megakaryo-
cytes (Zucker-Franklin and Kaushansky, 1996; Birk-
mann et al., 1997; Zauli et al., 1997; Schipper et al.,
1998) (Fig. 1). Furthermore, CD341-cell-derived
megakaryocytes have been shown to be positive for
CD4, the receptor for HIV-1 (Gewirtz et al., 1992; Kouri
et al., 1993; Zauli et al., 1995; Basch et al., 1996; Lee et
al., 1999) (Fig. 1). To determine the chemokine receptor
profile of primary megakaryocytes, CD341-cell-de-
rived megakaryocytes were labeled by immunofluo-
rescence using CXCR4-, CCR5-, and CCR3-specific
monoclonal antibodies. Confocal microscopy deter-
mined that the chemokine receptors CXCR4, CCR5,
and CCR3 were present in 100% of CD341-cell-de-
rived megakaryocytes (Fig. 1). Therefore primary
megakaryocytes express CD4, CXCR4, CCR5, and
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80 VOULGAROPOULOU, PONTOW, AND RATNERCCR3 and may be susceptible to infection by both X4
and R5 HIV-1 strains.
Infection of CD341-cell-derived megakaryocytes
by HIV-1
To determine whether CD341-cell-derived mega-
karyocytes were susceptible to infection by X4 and/or R5
HIV-1 strains, recombinant virus from the bone marrow of
HIV-1-infected patients was used for in vitro infections.
Infection of megakaryocytes by HIV-1 was detected by
double-labeled immunofluorescence using CD41 and
HIV-1 specific antibodies and cell staining was analyzed
FIG. 1. Antibody staining of CD341 hematopoietic progenitor cells
rown in Tpo media for 7 days. The mouse monoclonal antibodies used
ere CD41, CD4, CXCR4, CCR5, and CCR3 (1–2 mg of antibody per 106
cells). IgG1 and IgG2a (1–2 mg of antibody per 106 cells) were used as
isotype-matched negative control antibodies. Cells were stained with
anti-mouse IgG conjugated to PE (1:100 dilution).by confocal microscopy. Figure 2 shows that CD411
megakaryocytes were positive for staining by HIV-1 an-tisera following infection by both X4 and R5 HIV-1 strains.
Furthermore, HIV-1 strains from the bone marrow of TP
patients infected megakaryocytes to similar levels as
HIV-1 strains from the bone marrow and blood of non-TP
patients and the laboratory-adapted molecular clones
p120 and p125. Viral release from HIV-1-infected
megakaryocytes was measured to be ;190 pg of p24
per milliliter of culture supernatant, for all molecular
clones studied (data not shown). Furthermore, the p24
value was similar for all time points tested during the
13-day infection (Days 3, 6, 9, and 13) for all molecular
clones, suggesting that HIV-1 was constantly released
from the infected megakaryocytes into the supernatant
(data not shown). These results demonstrate that CD411
megakaryocytes were productively infected by both X4
and R5 HIV-1 isolates in vitro.
DISCUSSION
The primary determinant of HIV-1 pathogenesis is the
ntry of HIV-1 into susceptible cells. HIV-1 entry is facil-
tated through the interaction of the HIV-1 envelope gly-
oprotein on the surface of the virion with the HIV-1
eceptor molecules on the surface of target cells (Cairns
nd D’Souza, 1998; Lee et al., 1998). The HIV-1 cellular
eceptors have been identified as the differentiation
arker CD4 (Dalgleish et al., 1984; Klatzmann et al., 1984;
Maddon et al., 1986) and the chemokine receptors
CXCR4 and CCR5 (Deng et al., 1996; Dragic et al., 1996;
Feng et al., 1996). Other chemokine receptor molecules
have also been shown to function as HIV-1 coreceptors
in vitro (Choe et al., 1996; Doranz et al., 1996; Deng et al.,
997; Frade et al., 1997; He et al., 1997; Liao et al., 1997;
Loetscher et al., 1997; McKnight et al., 1997; Rucker et al.,
1997; Horuk et al., 1998; Jinno et al., 1998) but the bio-
logical significance of these molecules in vivo has not
been established. The available evidence suggests that
CXCR4 and CCR5 are the relevant chemokine receptors
in vivo (Huang and Carmichael, 1996; Samson et al.,
1996; Zhang et al., 1996; Smith et al., 1997; Stewart et al.,
997; Michael et al., 1998; Mummidi et al., 1998; Zhang
nd Moore, 1999) and are utilized by most or all HIV-1
solates (Rucker et al., 1997; Xiao et al., 1998). In addition
o CXCR4 and CCR5, the chemokine receptor CCR3 has
een suggested to play a role in HIV-1 neuro tropism (He
t al., 1997; Shieh et al., 1998; Zhang et al., 1998). Gen-
rally, CXCR4 mediates entry of T-cell tropic, syncytia-
nducing (SI) isolates into CD41 cells, whereas CCR5
ediates entry of macrophage tropic, non-syncytia, in-
ucing (NSI) isolates into these cells (Alkhatib et al.,
996; Deng et al., 1996; Dragic et al., 1996; Feng et al.,
1996; Speck et al., 1997).
In the present study, we aimed to determine whether
HIV-1 in the bone marrow of TP patients can infect
primary megakaryocytes in vitro, which may contribute to
the development of thrombocytopenia. We studied two
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81PRODUCTIVE INFECTION OF MEGAKARYOCYTESgroups of patients, patients with TP (A, B, and C) and
non-TP patients with hematopoietic dysfunction caused
by the invasion of bone marrow with neoplasms or op-
portunistic pathogens (D, J, and K). We constructed re-
combinant viruses using the V3 loop of HIV-1 envelope
from the bone marrow and blood of these patients (Voul-
garopoulou et al., 1999) and determined the chemokine
eceptor molecules utilized by the bone marrow and
lood HIV-1 strains and the chemokine receptor mole-
ules expressed on megakaryocytes. We showed that all
one marrow and blood HIV-1 isolates utilize CCR5 for
ntry into susceptible cells, irrespective of their ability to
eplicate in primary macrophages. The use of CCR5 by
ost HIV-1 primary isolates has been reported by others
Simmons et al., 1996; Clapham and Weiss, 1997; Cairns
and D’Souza, 1998) as well as the inability of several R5
HIV-1 strains to infect macrophages (Cheng-Mayer et al.,
FIG. 2. HIV-1 infection of CD341-cell-derived megakaryocytes. HIV-
sing CD41 monoclonal antibody (1–2 mg/106 cells) and pooled human
IgG1 isotype-matched antibody and human sera from HIV-1-infected pa
labeled with anti-mouse IgG conjugated to PE and HIV-1 antibodies w1997; Dittmar et al., 1997; Smyth et al., 1998; Hung et al.,
999). The T-cell tropic HIV-1 strains, characteristic of TPpatients, utilized CXCR4 for entry into susceptible cells,
whereas one TP and one non-TP HIV-1 strain utilized
CCR3. One notable exception was the T-cell tropic blood
isolate J/Bld47, which was able to replicate in MT-2 cells
but not in Jurkat and Hut78 T-cell lines (Voulgaropoulou
et al., 1999) and not in GHOST–CXCR4 cells (Table 1).
The ability of X4 HIV-1 isolates to infect some T-cell lines
but not others has been reported by others (Cheng-
Mayer et al., 1988; Connor et al., 1993; Dumitrescu et al.,
1994). Finally, we did not observe a correlation between
CCR3 utilization and thrombocytopenia because CCR3
utilizing HIV-1 strains were isolated from both TP and
non-TP patients. Therefore chemokine receptor analysis
revealed that X4 HIV-1 strains were present only in the
bone marrow of TP patients, whereas R5 HIV-1 strains
were present in the bone marrow of both TP and non-TP
patients.
ed megakaryocytes were detected by two-color immunofluorescence
m HIV-1-infected patients (1:100 dilution). Uninfected cells stained with
erved as negative control. The mouse monoclonal antibody CD41 was
eled with anti-human IgG conjugated to FITC (1:100 dilution).1-infect
sera froTo determine the susceptibility of megakaryocytes to
HIV-1 infection, we analyzed the chemokine receptor
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82 VOULGAROPOULOU, PONTOW, AND RATNERprofile of megakaryocytes using confocal microscopy.
Megakaryocytes were obtained from CD341 hematopoi-
etic progenitor cells grown in serum-free medium sup-
plemented with Tpo. Under these conditions, CD341
progenitor cells differentiate into CD411 megakaryo-
cytes after several days in culture (Zucker-Franklin and
Kaushansky, 1996; Birkmann et al., 1997; Zauli et al., 1997;
Schipper et al., 1998). Most importantly, these CD341-
cell-derived megakaryocytes have been reported to be
morphologically identical to bone marrow megakaryo-
cytes and to produce platelets in vitro that are indistin-
guishable from normal platelets (Choi et al., 1995a,b;
Cramer et al., 1997). We showed, in agreement with
published reports, that CD411 megakaryocytes express
surface CD4, CXCR4, and CCR5 (Gewirtz et al., 1992;
Kouri et al., 1993; Zauli et al., 1995; Basch et al., 1996;
Wang et al., 1998; Kowalska et al., 1999; Lee et al., 1999;
Riviere et al., 1999) and may be susceptible to infection
by both X4 and R5 HIV-1 strains. In addition, we report for
the first time, the presence of the CCR3 chemokine
receptor on CD341-cell-derived megakaryocytes. Our
results contradict the findings of Chelucci et al., who did
not detect CCR3 mRNA on cells of the megakaryocytic
lineage (Chelucci et al., 1999). Furthermore, Chelucci et
al. (1999) did not detect CCR5 on the surface of
megakaryocytes, an observation that contradicts our re-
sults and the results of others (Lee et al., 1999).
To determine whether primary megakaryocytes were
susceptible to infection by HIV-1, we exposed CD341-
cell-derived megakaryocytes to HIV-1 from the bone mar-
row of TP and non-TP patients. We showed that CD411
megakaryocytes were productively infected by both X4
and R5 HIV-1 strains. Our results contradict previous
reports on the susceptibility of megakaryocytes to T-cell
tropic but not macrophage tropic HIV-1 (Chelucci et al.,
1998, 1999; Lee et al., 1999). Furthermore, HIV-1 strains
from the bone marrow of TP and non-TP patients infected
megakaryocytes to similar levels. Because we did not
observe a difference in the ability of HIV-1 from TP or
non-TP patients to infect megakaryocytes, we believe
that the viral determinants of HIV-associated TP may lie
outside the V3 loop of HIV-1 envelope. Alternatively,
HIV-1 may cause TP indirectly as has been suggested by
others (Molina et al., 1990; Louache et al., 1992; Zauli et
al., 1992b,c).
In conclusion, we showed that the bone marrow of TP
patients is characterized by the presence of both X4 and
R5 HIV-1 strains, whereas only R5 HIV-1 strains were
present in the bone marrow of non-TP patients. HIV-1
from the bone marrow of TP and non-TP patients infected
megakaryocytes to similar levels, suggesting that the
viral determinants HIV-associated TP may lie outside the
V3 loop of the HIV-1 envelope. Furthermore, CD341-cell-
derived megakaryocytes express CD4, CXCR4, and
CCR5 and are productively infected by both X4 and R5
HIV-1 strains. Finally, we showed that CD341-cell-de-
(
(rived megakaryocytes express the chemokine receptor
CCR3.
MATERIALS AND METHODS
Infection of GHOST cells with recombinant HIV-1
The GHOST HIV indicator cells [GHOST (3) parental,
CXCR4, Hi-CCR5, and CCR3 (AIDS Research and Refer-
ence Reagent Program)] were used to determine the
coreceptor molecules utilized by the HIV-1 recombinant
clones for entry into susceptible cells. Briefly, 5 3 104
cells were infected with ;400 ng of HIV-1 p24gag over-
night in the presence of Polybrene (20 mg/ml). The next
ay the cells were washed, fed with fresh media and
aintained for 6 additional days, assaying for reverse
ranscriptase activity (RT) every 3 days. GHOST (3) cell
ines express uniformly high levels of CD4 and low levels
f endogenous CXCR4 (AIDS Research and Reference
eagent Program).
D341 cell isolation
CD341 cells were mobilized with granulocyte-colony
timulating factor and/or granulocyte macrophage-col-
ny stimulating factor from healthy volunteers after in-
ormed consent. Leukapheresis products were red cell
epleted and CD341 hematopoietic progenitor cells
ere isolated using the MACS CD34 progenitor cell-
solation kit, according to the manufacturer’s instructions
Miltenyi Biotec). Briefly, 2 3 109 cells were magnetically
abeled using hapten-conjugated CD34 monoclonal an-
ibody (clone QBEND/10) and an anti-hapten antibody
oupled to MACS MicroBeads. CD34-labeled cells were
ositively selected by passing them through MACS sep-
ration columns twice, to achieve 95% purity, and frozen
n 90% fetal calf serum [(FCS) (Gibco, BRL)] and 10%
MSO (Sigma) until needed.
onfocal microscopy
Approximately 1 3 106 cells were centrifuged on to
uperfrost Plus microscope slides (Fisher) using a
tatSpin Cytofuge (StatSpin, Inc.). Cells were fixed in
00% acetone or 4% paraformaldehyde for 10 min and
ncubated in PBS/BSA/Tween 20 buffer [13 phosphate-
uffered saline (PBS)/3% bovine serum albumin (BSA)/
.2% Tween 20] before the addition of antibodies. All
ntibody dilutions were made in PBS/BSA/Tween 20
uffer. Primary antibodies were incubated with cells for
h at room temperature and secondary antibodies were
ept on cells for 30 min at room temperature. Excess
ntibody was removed by washing in PBS/BSA/Tween
0 buffer for 10 min by gentle agitation. The mouse
onoclonal antibodies used were anti-human -CD41
clone PM6/248, Chemicon International Inc.), -CD4
clone QS4120, Calbiochem-Novabiochem Corp.), -CCR5
clones 2D7 and 5C7, AIDS Research and Reference
(
;
B
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83PRODUCTIVE INFECTION OF MEGAKARYOCYTESReagent Program), -CXCR4 (clone 44708.111, R&D Sys-
tems, Inc.), and -CCR3 (clone 7B11, AIDS Research and
Reference Reagent Program). Isotype controls were per-
formed using purified mouse IgG1 and IgG2a (Calbio-
chem). Pooled human sera from 10 HIV-1-infected pa-
tients were used as a source for antibodies against HIV-1
(the generous gift of Dr. Max Arens), which recognized
HIV-1 p24 and gp120 as detected by immunoprecipita-
tion of metabolically labeled virus and by Western blot
analysis of patient sera (data not shown). Mouse mono-
clonal antibodies were labeled with anti-mouse IgG con-
jugated to phycoerythrin (PE) (Boehringer Mannheim)
and HIV-1 antibodies were labeled using anti-human IgG
conjugated to fluorescein isothiocyanate (FITC) (Calbio-
chem-Novabiochem Corp.). Slides were mounted using
1% n-propyl gallate solution (50 mM EDTA/50% glycerol/
100 mM Tris pH 8.0) and antibody staining was detected
by Laser Scanning Confocal microscopy (Zeiss Axiovert
with Biorad confocal scanning imaging system).
Infection of megakaryocytes with recombinant HIV-1
CD341 hematopoietic progenitor cells were cultured
in Tpo media: StemPro-34 SFM serum-free medium
(Gibco, BRL) supplemented with 50 mg/ml thrombopoi-
etin (Tpo) (R&D Systems Inc.), 2 mM L-glutamine (Bio-
whittaker), and 100 mg/ml penicillin and streptomycin
Biowhittaker). At Day 7, 1 3 106 cells were infected with
400 ng of HIV-1 p24gag overnight. The next day, the cells
were washed extensively and cultured in Tpo media for
12–15 days. Every 3–4 days, one-third of the supernatant
was replaced with fresh Tpo media and viral release was
assayed by p24 ELISA (Coulter Corp.).
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